Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) has completed the acquisition of Ortho Transmission LLC, based in Colorado. The financial terms of the deal were not disclosed.
The acquisition includes technology developed by Ortho Transmission for transcutaneous systems for prosthetic limbs, which are meant to improve the mobility of amputee patients. Zimmer Biomet says the deal complements its ongoing collaboration in this field with the U.S. Department of Defense.
"Transcutaneous osseous integrated technology represents a fundamental innovation in limb replacement, and Zimmer Biomet is proud to leverage our musculoskeletal expertise to significantly improve the quality of life of amputee patients living in the United States and around the world," said Todd Davis, vice president & general manager of the global knee business. "This acquisition also perfectly aligns with our broad-based focus on clinically relevant innovations."
The company says it aims to leverage Ortho’s designs to offer the technology to patients, starting with a clinical trial. Ortho Transmission General Manager DC Hoffman says Ortho is excited to partner with Zimmer Biomet and accelerate the work on the technology.